Kopylov, U <br/><br/>
The efficacy of shortening the dosing interval to once every six weeks in Crohn's patients losing response to maintenance dose of infliximab.  [electronic resource] 

 -  Alimentary pharmacology & therapeutics  Feb 2011 
 - 349-57 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1365-2036 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2036.2010.04523.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Antibodies, Monoclonal--administration & dosage<br/>Crohn Disease--drug therapy<br/>Dose-Response Relationship, Drug<br/>Female<br/>Gastrointestinal Agents--administration & dosage<br/>Humans<br/>Infliximab<br/>Male<br/>Retrospective Studies<br/>Statistics as Topic<br/>Time Factors<br/>Treatment Outcome<br/>Young Adult